Skip to main content

Table 2 Sickle cell disease patients treated with hydroxyurea, characteristics

From: Sickle cell disease induces resistance to cutaneous carcinogenesis

Variable/Statistic All patients (n = 187)
Sex (% female) 62.6
Age (years), median (range) 31 (11–77)
Geographic origin
-Sub-Saharan Africa (%) 68.5
-French West Indies (%) 23.5
-Mediterranean region 6.4
-Madagascar 1.6
SCD genotype
-SS (%) 93
-Sb (%) 3.7
-SC (%) 2.6
-Sdpunjab (%) 0.6
Hydroxyurea treatment
- Duration (years), median (range) 6 (2–17)
- Daily dose (mg), median (range) 1100 (500–2000)
Skin cancer reported 0